These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31808505)

  • 1. Surgical versus percutaneous multivessel coronary revascularization in patients with chronic kidney disease.
    Kilic A; Sultan I; Gleason TG; Wang Y; Smith C; Marroquin OC; Thoma F; Toma C; Lee JS; Mulukutla SR
    Eur J Cardiothorac Surg; 2020 May; 57(5):994-1000. PubMed ID: 31808505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revascularization following non-ST elevation myocardial infarction in multivessel coronary disease.
    Huckaby LV; Sultan I; Mulukutla S; Kliner D; Gleason TG; Wang Y; Thoma F; Kilic A
    J Card Surg; 2020 Jun; 35(6):1195-1201. PubMed ID: 32362025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
    Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease.
    Mulukutla SR; Gleason TG; Sharbaugh M; Sultan I; Marroquin OC; Thoma F; Smith C; Toma C; Lee JS; Kilic A
    Ann Thorac Surg; 2019 Aug; 108(2):474-480. PubMed ID: 31056197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery disease.
    Kim DW; Om SY; Park MW; Park HW; Lee PH; Kang DY; Ahn JM; Lee CW; Park SW; Park SJ; Her SH; Park DW
    EuroIntervention; 2020 May; 16(1):27-35. PubMed ID: 31380780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
    Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
    J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization Strategies for Multivessel Coronary Artery Disease in the Elderly Population.
    Hess NR; Kilic A; Wang Y; Yoon PD; Navid F; Sultan I; Chu D
    J Surg Res; 2022 Feb; 270():444-454. PubMed ID: 34798427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
    Baber U; Farkouh ME; Arbel Y; Muntner P; Dangas G; Mack MJ; Hamza TH; Mehran R; Fuster V
    Eur Heart J; 2016 Dec; 37(46):3440-3447. PubMed ID: 27572072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease with Chronic Kidney Disease.
    Lin TC; Lu TM; Huang FC; Hsu PF; Shih CC; Lin SJ; Hsu CP
    Int Heart J; 2018 Mar; 59(2):279-285. PubMed ID: 29563384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched Analysis of Surgical Versus Percutaneous Revascularization for Left Main Coronary Disease.
    Huckaby LV; Sultan I; Ferdinand FD; Mulukutla S; Kapoor S; Thoma F; Wang Y; Kilic A
    Ann Thorac Surg; 2022 Mar; 113(3):800-807. PubMed ID: 33930354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimal strategy for coronary revascularization in patients with severe renal dysfunction.
    Komiya T; Ueno G; Kadota K; Mitsudo K; Okabayashi H; Nishiwaki N; Hanyu M; Kimura T; Tanaka S; Marui A; Sakata R;
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):293-300. PubMed ID: 25416698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    Ramanathan K; Abel JG; Park JE; Fung A; Mathew V; Taylor CM; Mancini GBJ; Gao M; Ding L; Verma S; Humphries KH; Farkouh ME
    J Am Coll Cardiol; 2017 Dec; 70(24):2995-3006. PubMed ID: 29241487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.